Published in Macromol Rapid Commun on September 27, 2016
Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials (2005) 7.55
Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis (1985) 7.44
The biology of platelet-derived growth factor. Cell (1986) 7.17
Porous scaffold design for tissue engineering. Nat Mater (2005) 5.00
Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol (1996) 4.67
Topographical control of cells. Biomaterials (1997) 4.31
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation (1998) 3.92
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol (2004) 2.99
Molecular mechanisms in intimal hyperplasia. J Pathol (2000) 2.83
Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation (1996) 2.77
Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol (2006) 2.74
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int (2000) 2.72
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting. Ann Thorac Surg (2015) 2.60
Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg (2010) 2.47
Modified classification of surgical meshes for hernia repair based on the analyses of 1,000 explanted meshes. Hernia (2012) 2.43
The role of the adventitia in vascular inflammation. Cardiovasc Res (2007) 2.21
Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis (2013) 2.16
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation (2000) 2.07
Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials (2009) 1.97
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg (2003) 1.79
Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol (2008) 1.77
Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis (1991) 1.75
Allogeneic human tissue-engineered blood vessel. J Vasc Surg (2011) 1.66
Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J Mater Sci Mater Med (1999) 1.61
Reduction of intimal and medial thickening in sheathed vein grafts. Ann Thorac Surg (1999) 1.60
Mechanical properties of synthetic implants used in the repair of prolapse and urinary incontinence in women: which is the ideal material? Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.58
Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. J Vasc Surg (2014) 1.58
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet (2016) 1.57
Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol (2013) 1.57
Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg (2005) 1.52
Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis (2009) 1.52
Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther (2014) 1.48
Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact Cardiovasc Thorac Surg (2011) 1.48
Femoro-distal bypass with varicose veins covered by prosthetic mesh. J Surg Res (2011) 1.47
Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg (1987) 1.47
Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg (2015) 1.43
Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol (2006) 1.41
Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts. Ann Biomed Eng (2006) 1.39
Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis (2011) 1.39
Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: a novel sheep model. Cardiology (2011) 1.39
Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ J (2010) 1.39
Saphenous Vein Graft Wrapping by Nitinol Mesh: A Word of Caution. Thorac Cardiovasc Surg (2014) 1.38
Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs (2003) 1.34
Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech (1998) 1.33
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation (2004) 1.29
Effect of compliance mismatch on vascular graft patency. J Vasc Surg (1987) 1.28
Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg (2013) 1.25
Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant (2007) 1.22
Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery (1989) 1.21
Animal models for the assessment of novel vascular conduits. J Vasc Surg (2010) 1.19
Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering. Adv Drug Deliv Rev (2009) 1.18
An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs. J Thorac Cardiovasc Surg (2002) 1.18
Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int (2008) 1.18
Strong and macroporous calcium phosphate cement: Effects of porosity and fiber reinforcement on mechanical properties. J Biomed Mater Res (2001) 1.17
Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering. Int J Nanomedicine (2014) 1.17
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation (1985) 1.17
Comparative analysis of histopathologic effects of synthetic meshes based on material, weight, and pore size in mice. J Surg Res (2011) 1.17
Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis. Am J Physiol Heart Circ Physiol (2009) 1.17
Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng (2005) 1.15
Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation (1994) 1.13
Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg (2009) 1.07
Tanned collagen arterial prosthesis of bovine carotid origin in man. Preliminary studies of enzyme-treated heterografts. Ann Surg (1966) 1.06
External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med (1998) 1.06
The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A (2010) 1.05
Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia. Ann Surg (1978) 1.05
Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. Regen Med (2012) 1.03
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg (2004) 1.03
Use of Wallstents for hemodialysis access-related venous stenoses and occlusions untreatable with balloon angioplasty. Radiology (1995) 1.03
Vascular graft infections: an update. Cardiovasc Surg (2001) 1.02
Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg (2004) 1.01
Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol (2005) 1.01
Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg (1997) 1.01
Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery (1984) 1.01
The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg (2001) 1.00
Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates. J Thorac Cardiovasc Surg (2008) 1.00
Mechanical behavior of coronary stents investigated through the finite element method. J Biomech (2002) 0.99
Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. J Biomed Mater Res A (2009) 0.99
Effect of porosity on the fluid flow characteristics and mechanical properties of tantalum scaffolds. J Biomed Mater Res B Appl Biomater (2005) 0.99
Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation (1996) 0.99
Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput (2007) 0.98
Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials (2003) 0.97
Mechanical properties of coronary stents determined by using finite element analysis. J Biomech (2001) 0.97
Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol (2010) 0.96
The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo. Biomed Mater (2011) 0.96
Understanding saphenous vein graft patency. Circulation (2011) 0.96
Retrieval study at 623 human mesh explants made of polypropylene--impact of mesh class and indication for mesh removal on tissue reaction. J Biomed Mater Res B Appl Biomater (2013) 0.95
Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation (2015) 0.94
The influence of porosity on the integration histology of two polypropylene meshes for the treatment of abdominal wall defects in dogs. Hernia (2007) 0.94
Molecular engineering of vein bypass grafts. J Vasc Surg (2007) 0.93
Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J (2002) 0.93
On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials (2006) 0.92
Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Vascul Pharmacol (2011) 0.92
Co-electrospun blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular tissue engineering. Biomacromolecules (2010) 0.92
Endothelium regeneration on luminal surface of polyurethane vascular scaffold modified with diamine and covalently grafted with gelatin. Biomaterials (2004) 0.91
Cell adhesion on gaseous plasma modified poly-(L-lactide) surface under shear stress field. Biomaterials (2003) 0.91